Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (101-110 of 220) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|March 14, 2018
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expressionBarbara J McClure, Susan L Heatley, Chung H Kok, et al.
Blood|May 16, 2002
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseRichard B Lock, Natalia Liem, Monica L Farnsworth, et al.
Neoplasia (New York, N.Y.)|May 2, 2013
Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complexRocco Piazza, Vera Magistroni, Angela Mogavero, et al.
Cancer Research|December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid LeukemiaAdele Baker, Gareth P Gregory, Inge Verbrugge, et al.
Plos One|April 6, 2012
Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenograftsBarbara Szymanska, Urszula Wilczynska-Kalak, Min H Kang, et al.
Annals of Hematology|October 25, 2013
Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growthHongbo Lu, Kensuke Kojima, Venkata Lokesh Battula, et al.
Plos One|July 18, 2019
MR susceptibility contrast imaging using a 2D simultaneous multi-slice gradient-echo sequence at 7TWei Bian, Adam B Kerr, Eric Tranvinh, et al.
Leukemia|January 11, 2013
Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemiaS H Oram, J Thoms, J I Sive, et al.
Revue Scientifique Et Technique (International Office of Epizootics)|June 18, 2021
A review of guidelines for evaluating a minor modification to a validated assayM M Reising, C Tong, B Harris, et al.
British Journal of Haematology|June 4, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemiaPatrick Connerty, John N Colgan, Fatima El-Najjar, et al.
Pageof 22

Showing results (101-110 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|March 14, 2018
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expressionBarbara J McClure, Susan L Heatley, Chung H Kok, et al.
Blood|May 16, 2002
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseRichard B Lock, Natalia Liem, Monica L Farnsworth, et al.
Neoplasia (New York, N.Y.)|May 2, 2013
Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complexRocco Piazza, Vera Magistroni, Angela Mogavero, et al.
Cancer Research|December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid LeukemiaAdele Baker, Gareth P Gregory, Inge Verbrugge, et al.
Plos One|April 6, 2012
Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenograftsBarbara Szymanska, Urszula Wilczynska-Kalak, Min H Kang, et al.
Annals of Hematology|October 25, 2013
Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growthHongbo Lu, Kensuke Kojima, Venkata Lokesh Battula, et al.
Plos One|July 18, 2019
MR susceptibility contrast imaging using a 2D simultaneous multi-slice gradient-echo sequence at 7TWei Bian, Adam B Kerr, Eric Tranvinh, et al.
Leukemia|January 11, 2013
Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemiaS H Oram, J Thoms, J I Sive, et al.
Revue Scientifique Et Technique (International Office of Epizootics)|June 18, 2021
A review of guidelines for evaluating a minor modification to a validated assayM M Reising, C Tong, B Harris, et al.
British Journal of Haematology|June 4, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemiaPatrick Connerty, John N Colgan, Fatima El-Najjar, et al.
Pageof 22